missing translation for 'onlineSavingsMsg'
Learn More

RB670 Mouse Anti-Human CD85k (Gp49b), BD OptiBuild™

Code produit 31793401 Tous les produits BD Biosciences Produits
Modifier l'affichage
Click to view available options
Quantité:
50 μg
Conditionnement:
50µg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Code produit Quantité Conditionnement
31793401 50 μg 50µg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.
Code produit 31793401 Fournisseur BD Biosciences Code fournisseur 770923
 Article restreint
Verfügbar ab: 27-11-2026
Add to basket
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

Mouse Monoclonal Antibody

CD85k (Gp49b) Monoclonal Antibody detects CD85k (Gp49b) in Human Samples. It is validated for Flow cytometry.
TRUSTED_SUSTAINABILITY

Specifications

Antigène CD85k (Gp49b)
Applications Flow Cytometry
Classification Monoclonal
Clone ZM3.8
Concentration 0.2 mg/mL
Conjugué RB670
Formule Aqueous buffered solution containing ≤0.09% sodium azide.
Alias de gène LILRB4; ILT-3; HM18; LIRB4; LIR-5
Espèces hôtes Mouse
Immunogène Human ILT3 Recombinant Protein
Méthode de purification Affinity Chromatography
Quantité 50 μg
État réglementaire RUO
Primaire ou secondaire Primary
Identification génétique (Entrez) 11006
Espèces cibles Human
Contenu et stockage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Forme Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.